WESTBROOK, ME - JANUARY 4: IDEXX Laboratories has been added to the Standard & Poor's 500 Index. (Photo by Ben McCanna/Portland Portland Press Herald via Getty Images) IDEXX Laboratories’ (IDXX) ...

Shares of IDEXX Laboratories Inc. IDXX slid 3.03% to $669.00 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.92% to 6,672.41 ...

IDEXX Laboratories continues to outperform the S&P 500, driven by strong recurring revenue and a robust customer ecosystem. IDXX delivered a double beat in Q3, with revenue up 13% and EPS up 21%, ...

IDEXX Labratories reported Q3 results that topped both EPS and revenue expectations while raising full-year guidance. EPS grew by 21% year over year, while revenue increased 13% year over year. Some ...

IDEXX Labratories reported Q3 results that topped both EPS and revenue expectations while raising full-year guidance. EPS grew by 21% year over year, while revenue increased 13% year over year. Are ...

It notched a beat-and-raise third quarter. It cited innovation and increased customer take-up as reasons for the solid growth it posted during the frame. Idexx published its third-quarter figures well ...

Idexx Laboratories was the top performer in the S&P 500 on Monday after the veterinary medicine company reported better-than-expected earnings and boosted its full-year outlook.

Nov 3 (Reuters) - IDEXX Laboratories (IDXX.O), opens new tab raised its full-year profit and revenue forecasts on Monday and reported better third-quarter results than last year, as the pet ...

IDEXX Laboratories Inc. (Nasdaq: IDXX) posted third-quarter earnings and revenue that exceeded market expectations and raised its financial outlook for the full year. The Westbrook-based maker of ...